The Anti-Semaglutide Antibody (M1HC), Human Chimeric (GenScript, A02296) was used at dilutions starting from 10 g/mL
Sergey Terushkin, MD, FACS (954) 551-3508 Absolutely
One limitation of the Harvard study was that patients were on semaglutide for a varied amount of time and developed NAION at various intervals from the start of the therapy, while a shorter interval of about 6 weeks should be expected for a drug-related complication
At Peak Performance, we primarily prescribe premium-quality compounded GLP-1 medications from state-licensed, FDA-registered compounding pharmacies
Speaking with a healthcare professional helps confirm that therapy continues safely within a supervised treatment plan
However, niacinamide does not directly address nausea